Orexo to Take Over PharmaKodex to Enhance Reformulation Business

PharmaKodex’ pipeline includes improved migraine and opioid-addiction drug. Orexo plans on acquiring PharmaKodex, a drug delivery company with expertise in the reformulation of small molecule...

WHO Gains Access to Schering-Plough Manufacturing Technology for Flu Vaccines

The organization will provide vaccines in developing countries. Schering-Plough will provide World Health Organization (WHO) with access to pandemic influenza vaccine manufacturing technology in developing...

Sandoz’ Biosimilar to Amgen’s Anemia Drug Gets EU Go-Ahead

Filgrastim obtained approval for the same range of indications as Neupogen. Sandoz received the green light to market its biosimilar to Amgen’s neutropenia treatment, Neupogen®,...

WIL Research Snags Midwest BioResearch

CRO gains genetic toxicity and biotech capabilities. WIL Research, a global CRO focused on early-stage toxicology and development, has acquired Midwest BioResearch (MBR), a Chicago-based...

OriGene Secures $6.5M to Set Up mAb Manufacturing Facility in China

Private equity financing enabled the company to complete its purchase of P&A biotech. OriGene Technologies raised $6.5 million, which allows it to complete the acquisition...

Merck & Co. to Pay $130M for Insmed’s FOBs and Production...

Company will give $10 million up front for two candidates and the rest at closing. Merck & Co. is offering $130 million for Insmed's pipeline...

Endo Inks Collaborations in Pain and Cancer

Firm will use Harvard delivery method for pain treatments and has signed on Aurigene to discover cancer therapies. Endo Pharmaceuticals entered two research collaborations for...

Promega and Celsis to Provide Solutions for ADME/Tox Testing in Primary...

Promega’s assays will be combined with Celsis’ lots of cryopreserved plateable hepatocytes. Promega entered an agreement with Celsis In Vitro Technologies, such that Promega will...

PPD to Acquire AbCRO

Move will increase company’s presence in central and eastern Europe. PPD entered into an agreement to acquire AbC.R.O. (AbCRO),  a contract research organization operating in...

Cell Therapeutics Looks to Cut Its Burn Rate by $14M

Company is looking to divest, partner, or form a JV for its preclinical business in Milan. Cell Therapeutics (CTI) has employed the services of Adjuvant...